Advanced heart failure is a growing problem for which the best treatment is cardiac transplantation. However, the shortage of donors’ hearts made left ventricular assist devices …

2023年8月8日 · Circulatory support with the use of a left ventricular assist device (LVAD) is an emerging field. The landmark REMATCH trial that compared LVADs with optimal medical …

Implantable left ventricular assist devices (LVADs) have emerged as a new treatment option for advanced heart failure as destination therapy for patients either too old or not suitable for …

2016年10月6日 · Left ventricular assist devices (LVAD) are increasingly being used as destination therapy (DT-LVAD) for patients with advanced heart failure (HF) who are not candidates for …

2018年12月10日 · Mechanical circulatory support (MCS) with ventricular assist device (VAD) is a safe and efficacious treatment strategy for patients with end-stage heart failure (HF) that is …

HeartMate3が2021年4月30日にDT（Destination Therapy：長期在宅補助人工心臓治療）適用となり保険収載されました。 それに伴い、DT実施基準に従い治療が開始されます。

2022年12月14日 · Durable implantable left ventricular assist devices (LVADs) have been shown to improve survival and quality of life for patients with stage D heart failure. Even though …

2019年10月21日 · The REMATCH trial (Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure) validated long-term mechanical circulatory support …

A left ventricular assist device (LVAD) is a mechanical pump that providers implant in people who have heart failure. The device helps the lower left chamber (left ventricle) of your heart pump …

Early clinical trials have demonstrated improved outcomes of durable left ventricular assist device (LVAD) support compared with optimal medical management. As technology advanced, …